Methimazole in children

Research objectives: Describe the clinical and subclinical characteristics in patients with Graves’ disease. Evaluation of Graves' disease treatment in children by anti-thyroid drug methimazole group synthesis. Survey and evaluate change TRAb levels and some clinical parameters, subclinical concerning treatment outcome and recurrence in children with Graves’ disease.

29p change03 06-05-2016 74 4   Download